2.42
-0.07 (-2.81%)
-0.07 (-2.81%)
Upgrade to Real-Time
Market Open
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.07 | -2.81% | 2.42 | 11:08:12 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 2.40 | 2.52 | 2.52 | 2.49 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.42 | 2.43 | 0.01 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 693 | 761,197 | $ 2.4365 | $ 1,854,690 | 4,462,515 | 0.261 - 10.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:08:09 | 100 | $ 2.42 | USD |
CytoDyn (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.37B | 569.32M | 302.11M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 23.36M | $ - | 0.00% | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.87 | 2.88 | 2.25 | 2.48 | 3,330,493 | -0.45 | -15.68% |
| 1 Month | 3.175 | 3.87 | 2.25 | 2.89 | 3,543,030 | -0.755 | -23.78% |
| 3 Months | 5.06 | 5.15 | 2.25 | 3.56 | 4,340,341 | -2.64 | -52.17% |
| 6 Months | 3.84 | 10.01 | 2.25 | 4.36 | 6,034,511 | -1.42 | -36.98% |
| 1 Year | 0.326 | 10.01 | 0.261 | 3.28 | 5,228,331 | 2.09 | 642.33% |
| 3 Years | 0.5675 | 10.01 | 0.0552 | 2.95 | 2,000,876 | 1.85 | 326.43% |
| 5 Years | 0.8957 | 10.01 | 0.0552 | 2.80 | 1,290,138 | 1.52 | 170.18% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
